Expression of TIMP-2 in HPV-16 infected oral squamous cell carcinoma in patients in Iraq

Aim: To determine the expression of tissue inhibitors of metalloproteinases (TIMP-2) in oral squamous cell carcinoma (OSCC) and the difference in its expression level between positive and negative HPV-16 (human papilloma virus- 16) OSCC patients. Methods: This study was conducted on 33 biopsies obtained from patients with OSCC and 10 normal oral mucosa as controls. In situ hybridization (ISH) was used to investigate the presence of HPV-16, while immunohistochemistry (IHC) was used to estimate the expression level of TIMP-2. Results: The TIMP-2 was expressed in 27 (81.8%) of OSCC sections with no significant difference between its expression level in HPV-16 positive and HPV-16 negative OSCC cases (p=0.058). TIMP-2 was found to be highly expressed in OSCC sections, and the presence of HPV was not related to its overexpression. Conclusions: The percentage of samples that appeared to accommodate detectable HPV-16 was high, but no significant difference was observed in relation to TIMP-2 expression level. Future studies with a larger number of patients are highly recommended to address the possible association between TIMp-2 and OSCC positive HPV-16.

• Publication year

  2016

• Venue

  Brazilian Journal of Oral Sciences

• Publication date

  2016-10-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.20396/BJOS.V15I1.8647123
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral squamous cell carcinoma in Iraq: clinical analysis

  2018cited by this paper
• NEDD 4 binding protein 2-like 1 promotes cancer cell invasion in oral squamous cell carcinoma

  2016cited by this paper
• Can MMP-9 be a Prognosticator Marker for Oral Squamous Cell Carcinoma?

  2016cited by this paper
• Oral squamous cell carcinoma associated with proliferative verrucous leukoplakia compared with conventional squamous cell carcinoma--a clinical, histologic and immunohistochemical study.

  2015cited by this paper
• Statement on mouth cancer diagnosis and prevention

  2014cited by this paper
• Association between human papillomavirus (HPV) and the oral squamous cell carcinoma: a systematic review

  2014cited by this paper
• THE EXPRESSION OF P53 AND MDM4 IN ORAL, LARYNGEAL AND CUTANEOUS SQUAMOUS CELL CARCINOMA; A COMPARATIVE STUDY BY TISSUE MICROARRAY

  2013cited by this paper
• The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases

  2013influential reference
• Tissue inhibitor of metalloproteinases in oral squamous cell carcinomas - a therapeutic target?

  2012cited by this paper
• HPV16 Oncoproteins Induce MMPs/RECK-TIMP-2 Imbalance in Primary Keratinocytes: Possible Implications in Cervical Carcinogenesis

  2012cited by this paper
• The Relationship between Oral Squamous Cell Carcinoma and Human Papillomavirus: A Meta-Analysis of a Chinese Population (1994–2011)

  2012cited by this paper
• The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma.

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• Expression of Matrix Metalloproteinases and Their Inhibitors in Squamous Cell Carcinoma of the Tonsil and Their Clinical Significance

  2011cited by this paper
• Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review

  2010cited by this paper
• Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma

  2010cited by this paper
• Matrix Metalloproteinases and Their Inhibitors: Correlation with Invasion and Metastasis in Oral Cancer

  2010cited by this paper
• Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.

  2009cited by this paper
• Oncogenic activities of human papillomaviruses.

  2009cited by this paper
• The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2

  2008cited by this paper
• Immunohistochemical and molecular genetic analysis of p 53 in oral squamous cell carcinoma (scc) in Hospital University Science Malaysia: a preliminary study

  2008cited by this paper
• Metalloproteinases and their inhibitors: Influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas

  2006cited by this paper
• Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers.

  2006cited by this paper
• Expression and Correlation of MMP-2. TIMP-2 in Oral Squamous Cell Cancer

  2005cited by this paper
• Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses

  2004cited by this paper
• Expressions of Matrix Metalloproteinases in Early-Stage Oral Squamous Cell Carcinoma as Predictive Indicators for Tumor Metastases and Prognosis

  2004cited by this paper
• Real-Time PCR-Based System for Simultaneous Quantification of Human Papillomavirus Types Associated with High Risk of Cervical Cancer

  2003cited by this paper
• Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.

  2002cited by this paper
• Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.

  2001cited by this paper
• Expression of tissue inhibitor of matrix metalloproteinase‐2 correlates with activation of matrix metalloproteinase‐2 and predicts poor prognosis in tongue squamous cell carcinoma

  2001cited by this paper
• Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.

  2001cited by this paper
• The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter

  2000cited by this paper
• Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer

  1999cited by this paper
• Human papillomavirus as a risk factor for head and neck cancers--a case-control study.

  1999cited by this paper
• High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.

  1997cited by this paper
• HPV immortalization of human oral epithelial cells: a model for carcinogenesis.

  1996cited by this paper
• High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.

  1996cited by this paper
• Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA.

  1987cited by this paper
• Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis.

  1983cited by this paper
• Cell by Direct Immunofluorecent Assay Detection of Human Herpesvirus Type-1 Antigen in Tissues of Oral Squamous Cell Carcinoma by Direct Immunofluorecent Assay

  year unknowncited by this paper

• Human Papilloma Virus Impact In Development Head And Neck Cancer

  2025cites this paper
• Impact of the Immunohistochemistry on appraisal of Oral Squamous Cell Carcinoma and Cervical Lymph Nodes Metastasis

  2024cites this paper